TransAtlantic Capital Financials

TransAtlantic Capital Stock Summary

TransAtlantic Capital competes with Third Millennium, Shanrong Biotechnology, Green Planet, and Azure Holding. Transatlantic Capital Inc. does not have significant operations. Transatlantic Capital Inc. was founded in 2002 and is based in Vallejo, California. Transatlantic Capital operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people.

TransAtlantic Capital Key Financial Ratios

TransAtlantic Capital's financial ratios allow both analysts and investors to convert raw data from TransAtlantic Capital's financial statements into concise, actionable information that can be used to evaluate the performance of TransAtlantic Capital over time and compare it to other companies across industries.

TransAtlantic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining TransAtlantic Capital's current stock value. Our valuation model uses many indicators to compare TransAtlantic Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TransAtlantic Capital competition to find correlations between indicators driving TransAtlantic Capital's intrinsic value. More Info.TransAtlantic Capital is rated fifth in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value TransAtlantic Capital by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for TransAtlantic Capital's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

TransAtlantic Capital Systematic Risk

Along with financial statement analysis, the daily predictive indicators of TransAtlantic Capital help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TransAtlantic Capital. We use our internally-developed statistical techniques to arrive at the intrinsic value of TransAtlantic Capital based on widely used predictive technical indicators. In general, we focus on analyzing TransAtlantic Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TransAtlantic Capital's daily price indicators and compare them against related drivers.

When running TransAtlantic Capital's price analysis, check to measure TransAtlantic Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransAtlantic Capital is operating at the current time. Most of TransAtlantic Capital's value examination focuses on studying past and present price action to predict the probability of TransAtlantic Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransAtlantic Capital's price. Additionally, you may evaluate how the addition of TransAtlantic Capital to your portfolios can decrease your overall portfolio volatility.